Calendar Amgen Inc.

Equities

AMGN

US0311621009

Real-time Estimate Cboe BZX 11:41:52 2024-05-21 am EDT 5-day change 1st Jan Change
312.5 USD -0.64% Intraday chart for Amgen Inc. +0.38% +8.53%

Chart calendar Amgen Inc.

1e0d1c7fd96dfd6402ba9e1b1680.O67uj9HfD-STqWo_nWagv7WnWAZdVtWoNteSFwUt-ME.SMGXxr24OIPV5yBdzgyQx-D3HTYYDpfrROPiSGdYqIZCxorN6bJ3isb2DQ~6b3bb2f7d3a78aaa7df9e84f8aeaf002

Upcoming events on Amgen Inc.

Today 02:30 pm American Thoracic Society Conference - Patient Characteristics and Treatment Patterns
Today 02:30 pm American Thoracic Society Conference - Effect of Tezepelumab on Exercise Tolerance
Today 02:30 pm American Thoracic Society Conference - Efficacy of Tezepelumab in Black or African American Patients
Today 02:30 pm American Thoracic Society Conference - Efficacy of Biologics for Reducing
Today 02:30 pm American Thoracic Society Conference - Effect of Biologics on Biomarkers
Today 02:30 pm American Thoracic Society Conference - Poster Session No. C34
Today 02:30 pm American Thoracic Society Conference - Poster Session No. C31
Today 05:15 pm American Thoracic Society Conference - Reduced Mucus Plugging with Tezepelumab
Today 05:15 pm American Thoracic Society Conference - Asthma Exacerbation Rates as a Function
2024-05-31 02:00 pm Annual General Meeting
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)
2025-02-03 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Amgen Inc.

2024-05-20 04:00 pm American Thoracic Society Conference
2024-05-20 12:50 pm American Thoracic Society Conference - Session No. B13
2024-05-20 12:15 pm American Thoracic Society Conference
2024-05-19 05:15 pm American Thoracic Society Conference - Phase 1 Safety and Efficacy of AZD8630/AMG104
2024-05-19 05:15 pm American Thoracic Society Conference - Greater Exacerbation Reductions with Earlier Biologic Initiat
2024-05-19 05:15 pm American Thoracic Society Conference - Session No. A101
2024-05-19 12:15 pm American Thoracic Society Conference - Efficacy and Safety of Avacopan Versus
2024-05-14 12:20 pm Bank of America Merrill Lynch Global Healthcare Conference
2024-05-02 04:30 pm Q1 2024 Earnings Call
2024-05-02 04:01 pm Q1 2024 Earnings Release
2024-03-09 07:50 pm American Academy of Dermatology Meeting
2024-03-09 07:15 pm American Academy of Dermatology Meeting - Abstracts No - #51067
2024-03-09 06:55 pm American Academy of Dermatology Meeting - Abstracts No - #50668
2024-03-09 12:20 pm American Academy of Dermatology Meeting
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #50233
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #52846
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #51480
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #51246
2024-03-05 09:10 am TD Cowen Health Care Conference
2024-02-22 04:00 pm Business Update Call

Past dividends on Amgen Inc.

2024-05-15 Quarterly 2.25 USD
2024-02-14 Quarterly 2.25 USD
2023-11-15 Quarterly 2.13 USD
2023-08-16 Quarterly 2.13 USD
2023-05-16 Quarterly 2.13 USD
2023-02-13 Quarterly 2.13 USD
2022-11-15 Quarterly 1.94 USD
2022-08-16 Quarterly 1.94 USD
2022-05-15 Quarterly 1.94 USD
2022-02-13 Quarterly 1.94 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
23 362
23 196
0.71%
25 424
25 363
0.24%
25 979
25 999
-0.08%
26 323
26 247
0.29%
28 190
28 108
0.29%

33 000

EBITDA
Million USD
Released
Forecast
Spread
13 363
13 029
2.56%
15 935
15 167
5.06%
15 822
16 002
-1.12%
16 178
15 935
1.53%
17 470
16 351
6.84%

18 705

EBIT
Million USD
Released
Forecast
Spread
11 157
11 138
0.17%
12 334
12 315
0.15%
12 424
12 479
-0.44%
12 761
12 728
0.26%
13 399
13 423
-0.18%

14 790

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
9 138
9 499
-3.8%
8 133
8 782
-7.39%
6 701
6 379
5.04%
7 346
7 466
-1.6%
7 855
8 859
-11.33%

4 605

Net income
Million USD
Released
Forecast
Spread
7 842
7 850
-0.1%
7 264
7 163
1.41%
5 893
5 598
5.27%
6 552
6 525
0.41%
6 717
7 401
-9.24%

4 133

EPS
USD
Released
Forecast
Spread
12,9
12,8
0.4%
12,3
12,0
2.4%
10,3
9,84
4.5%
12,1
12,1
0.41%
12,5
13,8
-9.66%

7,95

Announcement Date30/01/2002/02/2107/02/2231/01/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
6 238
6 111
2.08%
6 594
6 526
1.04%
6 652
6 556
1.47%
6 839
6 766
1.08%
6 105
6 177
-1.17%
6 986
6 680
4.58%
6 903
6 948
-0.65%
8 196
8 106
1.11%
7 447
7 453
-0.08%

8 321


8 434


8 808


8 099


8 592

EBITDA
Million USD
Released
Forecast
Spread
3 981
3 747
6.24%
4 163
3 953
5.31%
4 114
4 068
1.13%
3 920
3 744
4.7%
3 721
3 684
1.01%
4 411
4 152
6.25%
4 298
4 443
-3.25%
5 040
4 568
10.32%
4 477
4 373
2.37%

5 147


5 302


5 053







EBIT
Million USD
Released
Forecast
Spread
3 140
2 939
6.84%
3 335
3 152
5.8%
3 277
3 201
2.39%
3 009
2 976
1.11%
2 821
2 879
-2.01%
3 515
3 292
6.77%
3 403
3 424
-0.62%
3 660
3 689
-0.78%
3 078
3 164
-2.71%

3 790


3 910


4 019


3 657


3 975

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 675
2 243
-25.32%
1 531
2 046
-25.18%
2 392
2 021
18.36%
1 748
1 866
-6.32%
3 442
2 294
50.04%
1 614
2 402
-32.81%
1 947
2 183
-10.81%
852
1 517
-43.85%
-68,0
1 214
-105.6%

1 558


1 584


1 539


2 599


2 985

Net income
Million USD
Released
Forecast
Spread
1 476
1 725
-14.42%
1 317
1 749
-24.72%
2 143
1 665
28.68%
1 616
1 686
-4.16%
2 841
1 479
92.11%
1 379
1 840
-25.04%
1 730
1 772
-2.38%
767
1 308
-41.36%
-113
1 127
-110.03%

1 263


1 287


1 154


1 663


1 996

EPS
USD
Released
Forecast
Spread
2,68
3,24
-17.27%
2,45
3,28
-25.3%
3,98
3,06
30.15%
3,00
3,21
-6.6%
5,28
2,98
77.12%
2,57
3,40
-24.34%
3,22
3,29
-2.1%
1,42
2,36
-39.72%
-0,21
2,71
-107.75%

2,50


2,74


2,50


3,11


3,74

Announcement Date27/04/2204/08/2203/11/2231/01/2327/04/2303/08/2331/10/2306/02/2402/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW